Management of HCC during COVID-19: ILCA guidance
ILCA developed a guidance document on recommendations for the management of patients with liver cancer in the COVID-19 pandemic. This guidance document has been put together with the help and knowledge of ILCA Education Committee and Executive Committee.
Management of HCC during COVID-19: ILCA guidance – PDF
Management of HCC during COVID-19: ILCA guidance